US Patent 10131907 Glycoconjugates of RNA interference agents
Patent 10131907 was granted and assigned to Alnylam Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 29, 2014
Date of Patent
November 20, 2018
Patent Applicant
Patent Application Number
14500356
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10131907 Glycoconjugates of RNA interference agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.